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Directions and Challenges in Health Sciences
Research
by James B. Wyngaarden*
I want to tell you first ofall how pleased I am to
be in North Carolina again. Although it is now
more than six months since I moved to Bethesda,
this area is still home to me. I am delighted to be
here as Director of the National Institutes of
Health to participate in the dedication of this
magnificent facility-the first true home of the
National Institute of Environmental Health Sci-
ences since it was established 16 years ago this
month-and to launch today's science program in
which the achievements ofNIEHS scientists will
be presented.
This is a singular occasion for me-a coming
together with members of both of my NIH and
university families to talk about the great hu-
manitarian adventure of which we are a part.
This is an exquisitely exciting time in biomedical
research and I am happy to be a part of the
process ofpromoting its well-being and of ensur-
ing that its findings contribute to the health of
people here and around the world.
The new campus of the National Institute of
Environmental Health Sciences is an especially
appropriate place in which to discuss directions
and challenges in health sciences research.
Brought together here at "The Park" is a diverse
collection of outstanding talent, dedicated to the
task ofunravelling the mysteries ofenvironmen-
tal impacts upon biological systems, so that we
may all live more congenially in the air and soil
and sea around us. The difficulty of the task is
exceeded only by its importance. Ours is a job
that will never be completed-but that is part of
its fascination.
I view this Institute and its focus on the envi-
ronmental health sciences as a symbol of the
rounding out of the biomedical research arma-
mentarium ofthe NIH. This concept was summa-
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rized by my predecessor, Donald S. Fredrickson,
who told a congressional committee some years
ago that there are three great generic categories
of inquiry in biomedical science. One, he said, is
to understand biological systems. Another is to
understand how the genetic code determines the
fitness ofindividuals in regard to the functioning
oftheirbiological systems. Thethird, Fredrickson
said (1),
". . . is a question of how man and other animals
adapt to the environment and ecology in which they
live, and that adaptation is dependent both on the
nature of the environment and on the genetic struc-
ture...."
All three categories of inquiry are now being
vigorously pursued by the National Institutes of
Health. While the work ofall 11 ofour Institutes
is a collaborative effort that intermingles at
many levels, it is the specific charge ofNIEHS to
link the biological processes with the world
around us. The study ofthe interaction is a huge
task, and a vital one, if we are progressively to
break down the barriers to prevention and cure of
the chronic and degenerative illnesses that pres-
ently seem so formidable.
This Institute draws upon the knowledge base
ofNIH as a whole in pursuing its mission. In that
sense, it exemplifies the broad reach ofthe entire
agency. It conducts and supports research to de-
velop new knowledge germane to the processes by
which human health can be adversely affected by
the environment. This involves a broad spectrum
ofdisciplines and approaches, ranging from basic
studies of molecular and cell biology to research
associated with the detection ofhazardous chemi-
cals, and with the extrapolation of laboratory
data to man, andthe estimation ofrisks ofhuman
exposure.
For example, through his chairmanship of the
National Thxicology Program, Dr. Rall leads a
Departmental effort to strengthen the science
base in toxicology, to test potentially toxic chemi-J. B. WYNGAARDEN
cals, and to develop more sensitive and rapid
methods fortestingtoxicity. Theprogramhelps to
avoid duplication ofeffort and provides a vehicle
for settingpriorities among chemicals ofconcern.
The information developed through NIEHS is
essential in designing effective disease preven-
tion strategies. This Institute has identified pre-
vention of environmentally related diseases as a
majorpriority. Inthis fiscal year (1983), forexam-
ple, the Institute expects to devote approximately
90% ofits budget to activities considered disease
prevention.
The mechanisms by which environmental
agents contribute to chronic and degenerative
diseases remain poorly understood. Nevertheless,
there is no question that the environment-man-
made and natural-is a major factor in disease
anddisability. I ampersonally persuaded thatthe
relationship is greater than has heretofore been
appreciated. Recent findings point increasingly
toward the causal importance ofdietary, occupa-
tional, industrial, and other environmental fac-
tors in several of the major diseases of today.
Many of these factors result from activities that
are subject to human control. Many are by-prod-
ucts ofmodern technology and, therefore, require
continuous balancing of social benefits against
health risks by policymakers in our government.
We cannot achieve a zero-risk society, but it is
appropriate that the people themselves, through
their elected representatives, decide which risks
are worth taking.
I have described NIEHS as a symbol of the
broad, integrated approach to the pursuit of
biomedical knowledge andthe conquest ofdisease
that is followed by NIH as a whole. There is
another vital aspect of this approach that must
also be emphasized; that is, the larger community
ofeffortthattranslates newknowledge into medi-
cal practice and measures for health mainte-
nance.
The makeup of this larger scientific research
community underscores the fact that there is no
Federal monopoly on health research. We include
in the research communtiy, laboratories at pub-
licly supported and private colleges, universities,
academic health centers and teaching hospitals,
the laboratories of industry and the work sup-
ported by voluntary organizations and founda-
tions. The breadth of NIH programs is indicated
by the fact that well over four-fifths of NIH ex-
penditures support extramural biomedical re-
search in universities, private laboratories, and
elsewhere. While the NIH campus in Bethesda
(and its extension here) is the largest single
biomedical research institution in the world, our
intramural research programs account for only
about one out ofevery $25 spent on such work in
the United States.
The support ofbasic research is aresponsibility
ofGovernment, for the dual reasons that it bene-
fits the people and the economy ofthe nation and
that there is no other substantial source for its
support. The bulk ofsupport for basic biomedical
research, conducted mainly in university labora-
tories, will continue to come from the Federal
Government, primarily through NIH. In 1981, for
example, 78% ofhealth R&D funds used by uni-
versities came from the Federal Government;
19% from university, state, local, and other non-
profit sources; and 3% from industry. While in-
dustry has an important role in the continuum of
health science research, its emphasis is chiefly on
development and application. Theprimary search
for basic knowledge will continue to be conducted
by universities and Federal laboratories, with
Federal dollars.
We are now entering the fifth decade of the
Federal-academic partnership in biomedical re-
search. We can take adegree ofencouragement in
making predictions for the 1980s from the fact
thatthe principles shaping thatpartnership have
changed little since the years immediately after
World War II. A number of issues we face in the
1980s were foreseen in the 1940s-for example,
what to do about obsolescent equipment and in-
strumentation, patents, indirect costs, rising di-
rect costs, and small business involvement. The
Federal approach to support of health research
through universities has served the national in-
terestwell throughtheyears. Thebasicconceptof
the Federal-academic partnership was expressed
in a 1945 report entitled, "Science-The Endless
Frontier," written by Dr. Vannevar Bush, the
President's Science Advisor (2). The flavor and
substance of the document stand up well when
viewed from the perspective of nearly 40 years.
Permit me to read a few sentences from it:
"The publicly and privately supported colleges,
universities, and research institutes are the centers
ofbasic research. They are the wellsprings ofknowl-
edge andunderstanding. As long asthey are vigorous
andhealthy andtheirscientists are free to pursuethe
truth wherever it may lead, there will be a flow of
new scientific knowledge. ... Progress in the war
against disease results from discoveries in remote
and unexpected fields ofmedicine and the underlying
sciences."
Such "discoveries in remote and unexpected
fields" are the objective of the Government-uni-
versity partnership. A concept expressed in the
1920s by Alfred North Whitehead characterizes
our present effort. Whitehead said (3): "The
272DIRECTIONS AND CHALLENGES INHEALTH SCIENCES RESEARCH
proper function ofa university is the imaginative
acquisition ofknowledge." I like to think that this
concept can be applied to the function of NIH as
well.
An isolated fact is interesting but not useful
until imagination places it in a larger context. At
that point, as Whitehead said in the same lecture
(3), "a fact is no longer a bare fact: it is invested
with all its possibilities." Tb be engaged in "the
imaginative acquisition of knowledge" at this
time is, in my opinion, the most exciting opportu-
nity in the history ofhealth science research. The
recent flood of advances in biomedical research
hasjustifiably led to the use ofthe phrase "biolo-
gical revolution" to describe the present state of
the life sciences. This surge of new knowledge,
the result ofmore than three decades ofvigorous
public support of biomedical research, has pro-
duced outstanding opportunities for progress and
has created an unprecedented potential for the
application ofthis knowledge to the improvement
ofhealth. The barriers are comingdown; biomedi-
cal science has probed the innermost secrets of
living processes at the cellular and molecular
levels. Let me mentionjust a few ofthese areas of
high promise to be pursued in the immediate
future:
First, the development of recombinant DNA
technology has given us an exciting tool that
allows us to transfer hereditary units from one
species to another and permits bacteria to become
factories for the production ofsubstances ofbiolo-
gical, agricultural, and medical importance. The
use of this technique has already led to the syn-
thetic production ofhuman insulin, somatostatin
and growth hormone. Recombinant DNAtechnol-
ogy also canbe used to produce large quantities of
pure antigen which, in turn, can be used as vac-
cines for immunization against infectious agents.
Second, the development of hybridoma cell fu-
sion technology has led to facile production of an
array of monoclonal antibodies for use in exqui-
sitely specific vaccines, diagnostic tests, and
treatment for many diseases. Recently, investiga-
tors have usedhumanlungcancer cells to prepare
monoclonal antibodies that candistinguish tumor
cells from normal cells. This technology may per-
mit the detection ofcancer at a very early stage.
In a few instances, clinicians have been able to
attach radioactive or chemotherapeutic agents to
the antibodies and thereby kill cancer cells with-
out harming surrounding healthy tissue.
Third, the past decade has seen rapid growth in
our knowledge ofneurobiology; we are achieving
a progressively better understanding ofthe func-
tion of the brain and central nervous system in
health and disease. The discovery ofslow viruses
that cause significant neurological damage has
been a major advance. Methods of opening the
blood-brain barrier selectively have been identi-
fied and are being investigated to allow enzyme
replacement in certain genetic diseases. Progress
inmicrosurgery has greatly improvedthe outlook
for patients with certain neurological conditions,
including brain tumors and acoustic neuroma.
New diagnostic tools, including computerized ax-
ial tomography (CAT), positron emission transax-
ial tomography (PETT) and, most recently, nu-
clear magnetic resonance (NMR), allow detailed
imaging ofthe living human brain and its func-
tions and promise to uncover a wealth of knowl-
edge. Work onneurotransmitters, such as L-Dopa,
and neuropeptides, such as encephalins, has
greatly expanded our knowledge of communica-
tion within the central nervous system. I agree
with many scientists who believe that neurobiol-
ogy is the frontier science ofthis decade.
Fourth, a major concept of cancer causation,
introduced in the 1960s, continues to gain sup-
port from new sero-epidemiological evidence.
This is the concept of oncogenes-genes that
cause tumors. Like other genes, these serve as
templates for DNA that direct the production of
enzymes that, in turn, catalyze the synthesis or
modification of proteins. The protein products
have been called oncogenic proteins, since their
action causes neoplastic transformation of cells.
"Onc" genes have been detected in a wide variety
of vertebrate species, including man. The onco-
gene concept suggests that in the course ofevolu-
tion an RNA-type virus became incorporated in
the germline, or genome, and exists there as a
silent infection before birth. It is proposed that
these genes can be activated by a myriad ofenvi-
ronmental agents that then serve as proximate
causes ofcancer.
Scientific advances such asthese formthe deep-
eningfoundationuponwhichwe will build impor-
tant achievements and health benefits in the
years ahead. They will not come quickly or easily,
but there is a momentum to science that will not
be denied. There is much to do. We still do not
understand the fundamental processes and mech-
anisms of heart disease, cancer, stroke, schizo-
phrenia, arthritis, diabetes, and other major dis-
eases. We must set our priorities in full
awareness ofthe enormous toll ofsuch disorders,
but also with a realistic assessment ofthe exist-
ing state ofknowledge and the readiness for dis-
covery in each field.
The rate of progress in the ceaseless war on
disease is a function of scientific opportunity,
273J. B. WYNGAARDEN
which we now have in abundance, the imagina-
tive insight ofscientists, and available funds. We
are simultaneously involved in the adventure of
discovery for its own sake and in pursuit ofbetter
health for all. What a combination: satisfying
work in a great humanitarian cause!
But how shall we make sure that the momen-
tum ofscientific discovery is continued? We have
entered a period offinancial constraint in biome-
dical science. The period of explosive growth of
support for biomedical research ofthe fifties and
sixties, when the NIH budget increased 20-fold in
constant dollars in 13 years, is long over. The
second stage rocket of the cancer, heart disease
and stroke initiative has now played out. After
reaching an all-time high in constant dollars in
1979, the NIH budget has leveled off, and has in
the past three years declined about 12% in the
same dollars. The NIH is now a mature agency
competing with other Federal programs for its
share ofthe budget. In the context ofthe present
economy NIH has been well treated by the Ad-
ministration and the Congress, but it cannot an-
ticipate extraordinary growth in the foreseeable
future. In my view, we are facing more than a
temporary funding constraint in biomedical sci-
ence; rather, we have entered a new steady state
that, all ofus, NIH and universities alike, would
do well to view as the future norm. A number of
painful adjustments will be necessary ifwe are to
secure the greatest amount of the best science
within our available resources. Since it may not
be possible to continue all the efforts and pro-
grams we have come so passionately to cherish,
we will have to set our research priorities care-
fully, taking into consideration a wide variety of
factors: the overall mission of NIH to support
research in pursuit ofhealth, scientific consider-
ations, and specific public mandates and assign-
ments asexpressedby Congress andtheAdminis-
tration. Whatever our priorities and programs,
which may vary as conditions and opportunities
warrant, there are certain abiding principles that
will continue to guide our decisions.
One is that the pursuit of basic knowledge is
the foundation of all progress in the health sci-
ences. We must continue to increase our store of
fundamental knowledge. Any relaxation of that
necessarily long-term objective in favor of short-
term advantage is a threat to the eventual tri-
umph over disease and suffering.
A second fundamental principle is that investi-
gator-initiated research into biological processes
holds the greatest promise of significant discov-
ery. Through competing research projects, we tap
the best minds and most creative ideas, weigh
them through peer review ofsubstance and meth-
odology, and test them through challenge and
openexchange ofinformation. Wewill continueto
place top priority on the award of new and com-
petingresearch project grants, and on the support
of such projects for the life of the award period.
Incidentally, in fiscal year 1982, which ended on
September 30, we managed to fund 5030 such
new and competing renewal awards.
Finally, the third element of these timeless
principles is that there is a continuing need to
assure a supply ofwell-trained scientists to carry
out the research to meet national health goals.
There is a close interrelationship between the
continued productivity ofresearch and the avail-
ability and replenishment ofthe supply of quali-
fied investigators.
Beyond those statements ofprinciples are cer-
tain other responsibilities that also must be con-
sidered by NIH. We must recognize a need for
balance between the fundamental pursuits and
other NIH program components in orderto assure
uninterrupted progress in all segments. Among
those additional components are the following
six:
* Research centerswhich conductmultidiscipli-
nary research focused on specific health prob-
lems, integrate basic research with clinical appli-
cation, and provide a vehicle for transferring new
scientific knowledge into practice in community
health care settings.
* Research resources to strengthen, enhance,
and maintain the quality of the environment in
which biomedical research is performed.
* Biomedical communications involving the ac-
quisition, storage, and dissemination ofinforma-
tion needed in research, health professional edu-
cation, and the delivery ofhealth care services.
* International research activities to facilitate
the exchange of scientific information and pro-
mote collaborative research efforts.
* Clinical trials to advance knowledge concern-
ing the prevention, diagnosis, and treatment of
disease and to provide evidence of safety and
efficacy ofnew therapy.
* Special emphasis on the prevention ofdisease
and the promotion ofhealth as part of a Depart-
ment-wide initiative.
These, then, are the major responsibilities of
NIH which must be weighed in establishing our
priorities and programs for the future. But the
underlying principles on which all ofour work is
built remain the pursuit of basic research, sup-
port ofindependent investigators and their ideas,
and the training offuture scientists.
Closer tohome, here atNIEHS, majorprogram-
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matic efforts as demonstrated in the poster ses-
sions illustrate the broad nature of modern
biomedical inquiry-genetic toxicology, reproduc-
tive and developmental toxicology, and health-
risk estimation. Many of these areas involve re-
search under way in other Institutes as well.
Atpresentations this afternoon you will hear of
a studytobe made ofenvironmental factorspossi-
bly involved in renal failure. These agents in-
clude lead, cadmium, analgesics, and solvents.
What, ifany, is the connection with renal failure?
What are its dimensions? And by what processes
might it lead to pathology? You will also be told of
investigations into asbestos-induced lung disease
andeffects ofcertain chemicals onthemale repro-
ductive system. Merely naming these topics of
inquiry indicates the wide-ranging potential ef-
fects of environmental substances on various or-
gan systems and the broad scope ofstudies on the
NIEHS agenda.
Raised levels of aluminum and zinc have been
associated with dementias that occasionally occur
during the course of chronic renal dialysis. A
possible role ofaluminum has also been proposed
in chronic dementia of the Alzheimer's type, but
this hypothesis has prompted considerable con-
troversy. Scientists supported by NIEHS have
now confirmed findings ofraised aluminum levels
in the brains ofAlzheimer's disease patients, and
have devised a means to pinpoint the site of
aluminum concentrations in the hippocampus of
the brain. The question of the etiological role of
aluminum, if any, remains open, but the investi-
gation continues.
A final instance that I would like to cite con-
cerns unexpected findings made by NIEHS scien-
tists who were investigating effects of the estro-
gen DES on children of mothers who used this
hormone during pregnancy. In experimental
studies in rats given DES, they discovered abnor-
mal developmental ofgenitalia in male offspring.
Subsequently, other scientists reported findings
that male offspring of DES rat "mothers" were
sterile. This outcome has since also been observed
in clinical practice.
These are illustrations of the sometimes sur-
prising findings that prompt further study and,
thereby, lead us closer to the answers we seek.
The prospects are clearly for greater-than-ever
achievement in the future; the record ofthe past
gives us reason for confidence.
I believe that the strong and healthy partner-
ship ofNIH and the universities ofthis country,
based on long-standing principles of cooperation
in the cause of science, will serve us well in
arriving at mutually agreeable and productive
solutions to the problems we face.
As we confront the issues of the 1980s and
beyond, we must renew our commitment in sup-
port of the overriding objectives we share-the
conquest of disease and better health for all.
Through our joint pursuit of the "imaginative
acquisition ofknowledge," I am confident that we
will continue to move steadily toward realization
ofour goals.
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